email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
1876 - 1890
of 3630 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
Next
AkesoBio Completes $335 Million Hong Kong IPO; Climbs 50% on First Trading Day
$5.00
Available
Innovent's sNDA for Use of PD-1 in NSCLC Accepted for China Review
$5.00
Available
Hansoh In-licenses Novel Anti-Viral from NiKang in Deal Worth up to $100 Million Plus
$5.00
Available
APTBIO of Shanghai Completes $28 Million Round for Proteomics Services
$5.00
Available
CStone Says NDA for GIST Precision Medicine Accepted for Review in China
$5.00
Available
Sinovac Reports Positive Animal Data on COVID-19 Vaccine; New Plant to Produce Vaccine
$5.00
Available
Magpie Pharma Closes $14 Million Funding for Modernized TCM Drugs
$5.00
Available
ChosenMed of Beijing Completes B Round for Oncology Precision Medicine
$5.00
Available
Harbour BioMed Starts China POC Trial of Novel mAb in Autoimmune Disease
$5.00
Available
New Horizon Health Raises $20 Million for China Early-Stage Cancer Tests
$5.00
Available
US Approves Fosun Pharma's COVID-19 Test Kit under Emergency Rules
$5.00
Available
Mabspace Cleared to Start US Trial of ADCC Molecule in Solid Tumor Cancers
$5.00
Available
Cloudbreak, a US-China Biopharma, Raises $25 Million for Ophthalmology Drugs
$5.00
Available
Chi-Med Granted US Fast Track Designation for Surufatinib in Pancreatic Neuroendocrine Tumors
$5.00
Available
Beijing Mabworks Closes $160 Million C1/C2 Round for Biologic Drugs
$5.00
Available